KLST/Kallistatin Polyclonal Antibody

Sizes: 50µl, 100µl

Catalogue Numbers: BS65922-50, BS65922-100

Product: 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Swiss-Prot: P29622

Host: Rabbit

Reactivity: Human, Mouse, Rat,

Applications: WB

All Applications: WB=1:500-2000

Background: Kallistatin is a serine proteinase inhibitor which binds to tissue kallikrein and inhibits its amidolytic and kininogenase activity. Inhibition is achieved by formation of an equimolar, heat- and SDS-stable complex between the inhibitor and the enzyme, and generation of a small C-terminal fragment of the inhibitor due to cleavage at the reactive site by tissue kallikrein. Heparin blocks kallistatin's complex formation with tissue kallikrein and abolishes its inhibitory effect on tissue kallikrein's activity.

Purification and Purity: affinity purified by Protein A

Storage and Stability: Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.

Specificity: KLST/Kallistatin Polyclonal Antibody detects endogenous levels of KLST/Kallistatin protein.

Bioworld Molecular Weight: 50 kD

Note: For research use only, not for use in diagnostic procedure.

Extra Notes: Primary: Anti-KLST/Kallistatin at 1/1000 dilution

Alternative Name: Serpin peptidase inhibitor clade A member 4; Kallikrein binding protein; Kallikrein inhibitor; Protease inhibitor 4; Serpin A4; KAL; Kallikrein binding protein; Kallikrein inhibitor; KBP; KLST; KST; MGC108582; PI4; Protease inhibitor 4; Serpin A4; Serpin peptidase inhibitor clade A member 4; SERPINA4; KAIN_HUMAN.

Immunogen: KLH conjugated synthetic peptide derived from human KLST/Kallistatin:151-250/427

Conjugate: Unconjugated

Modification: Unmodified